ROCKVILLE, Md., Dec. 11, 2015 (GLOBE NEWSWIRE) -- The Regulatory Affairs Professionals Society (RAPS) announced today the retirement of its Executive Director Sherry Keramidas whose leadership during a 20-year tenure helped advance the healthcare regulatory profession. She will retire on 31 January 2016.
"Sherry has served RAPS and its members during a critical period of change in the healthcare industry," according to RAPS Chairman of the Board Rainer Voelksen. "Her constancy throughout ensured RAPS' mission to provide leading education and professional development opportunities and credentialing to regulatory professionals. The RAPS Board of Directors extends its deepest appreciation to Sherry for her two decades of stewardship and commitment to RAPS members, partners and Board."
"It's been my pleasure to serve RAPS during a period of unprecedented change in the healthcare industry," said Keramidas. "The regulatory environment will continue to rapidly evolve and I retire from RAPS confident that the advancement of its professionals will continue to be the defining commitment of this organization's leadership."
The Board's top priority during the transition to new leadership is to ensure RAPS' continuity in fulfilling day-to-day operations that deliver on the organization's commitment to programming and other essential functions that serve its members and partners. Sherry will help facilitate the transition by working with the Executive Committee of the Board to provide support on specific key initiatives.
The Board has initiated a search for a new executive director and will be announcing a plan for interim leadership in the coming weeks. It has established a Search Committee of the Board and will engage a professional recruiting firm to conduct the search for the permanent executive director.
With questions or for more information, please contact RAPS President Martha A. Brumfield at [email protected].
About RAPS
The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Shanghai and Singapore, and chapters and affiliates worldwide. RAPS.org
CONTACT: Zachary Brousseau
Senior Manager, Communications
RAPS
+1 301 770 2920, ext. 245; [email protected]


SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 



